Molecular diagnosis availability in cancer assistance: a laboratory perspective

Authors

  • Juliana Garcia Carneiro Laboratorio Personal

DOI:

https://doi.org/10.61229/mpj.v1i2.23

Keywords:

Precision Medicine, genetic panels, molecular diagnosis, oncology, target treatment

Abstract

Latest years have been followed by substantial achievements in cancer treatment. Precision medicine is a new approach based on molecular profile assessment of each patient. Individual genetic profile is considered when evaluating patient's risk assessment, as well as the genetic profile of the tumor, which can influence response to treatment. Laboratories offer a wide range of genetic tests to ensure a targeted diagnosis for each situation. These laboratories play a crucial role in welcoming patients and ensuring the quality of these exams. Furthermore, they may experience many questions from doctors and patients about the exams and their application in their daily routine. This article addresses the main challenges related to precision medicine in oncology treatment. This new approach is very promising and has benefited many cancer patients. However, some challenges in the application of precision medicine have still been observed, which makes it difficult for patients to access more personalized treatments

Downloads

Download data is not yet available.

References

Cancela MC, Monteiro Dos Santos JE, Lopes de Souza LB, Martins LFL, Bezerra de Souza DL, Barchuk A, et al. The economic impact of cancer mortality among working-age individuals in Brazil from 2001 to 2030. Cancer Epidemiol. 2023 Aug 12;86:102438. doi: 10.1016/j.canep.2023.102438 DOI: https://doi.org/10.1016/j.canep.2023.102438

Published

2023-11-30

How to Cite

Garcia Carneiro, J. (2023). Molecular diagnosis availability in cancer assistance: a laboratory perspective. Mário Penna Journal, 1(2), 82–86. https://doi.org/10.61229/mpj.v1i2.23